propranolol has been researched along with sirolimus in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 4 (14.29) | 29.6817 |
| 2010's | 18 (64.29) | 24.3611 |
| 2020's | 5 (17.86) | 2.80 |
| Authors | Studies |
|---|---|
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Crowe, A; Lemaire, M | 1 |
| Comellas, A; Guerrero, C; Pesce, L; Ridge, KM; Sznajder, JI | 1 |
| Bennett, T; Fallgren, B; Gardiner, SM; Kemp, PA; March, JE | 1 |
| Akyüz, C; Ataş, E; Varan, A | 1 |
| Braunschweiger, F; Rössler, J; Schill, T | 1 |
| Bischoff, J; Huang, L; Klagsbrun, M; Mulliken, JB; Nakayama, H | 1 |
| Ito, S; Miyazaki, O; Mori, T; Nakazawa, A; Terashima, K; Uno, T | 1 |
| Blagosklonny, MV | 1 |
| Arnould, T; Brohée, L; Colige, AC; Demine, S; Deroanne, CF; Willems, J | 1 |
| Baselga, E; Bonnet, D; Boon, LM; Ciofi Degli Atti, M; El Hachem, M; Harper, JI; Hoeger, PH; Léauté-Labrèze, C; Oranje, AP; Rubin, AT; Weibel, L | 1 |
| Chen, G; Ren, JG; Zhang, W; Zhao, YF; Zhu, JY | 1 |
| Trenor, CC | 1 |
| Kurtz, J; Sears, D; Spier, AB | 1 |
| Diaz, L; Levy, M; Warren, D | 1 |
| Boccara, O; Léauté-Labrèze, C; Maruani, A | 1 |
| Dillingham, CS; Givner, LB; McLean, TW; Rinker, EK; Russell, TB | 1 |
| He, X; Li, Y; Tan, C; Wang, H; Wu, B; Wu, Y; Xu, B; Yu, G | 1 |
| Josephs, S; Lekwuttikarn, R; Teng, JM | 1 |
| Cheung, K; Chew, AN; Connor, DE; Cooley-Andrade, O; Gerbelli, J; Goonawardhana, D; Parsi, K | 1 |
| Baselga, E; Dávila-Osorio, VL; Iznardo, H; Puig, L; Roé, E | 1 |
| Andrulis, M; Bieksiene, K; Dimiene, I; Miliauskas, S; Optazaite, DE; Vaguliene, N; Zaveckiene, J; Zemaitis, M | 1 |
| Caputi, M; Cerasoli, G; Cerretani, E; Corradini, E; Falco, A; Frati, C; Gherli, A; Gnetti, L; Graiani, G; Lagrasta, C; Lorusso, B; Madeddu, D; Nogara, A; Pilato, FP; Quaini, F; Roti, G | 1 |
| Dubinski, I; Häberle, B; Küppers, J; Lurz, E; Schmid, I; Schmidt, H; Walther, A | 1 |
4 review(s) available for propranolol and sirolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Koschei the immortal and anti-aging drugs.
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Caloric Restriction; Exercise; Folklore; Gene Expression; Glucose; Humans; Insulin Resistance; Longevity; Metformin; Propranolol; Russia; Sirolimus; TOR Serine-Threonine Kinases | 2014 |
Treatment of infantile haemangiomas: recommendations of a European expert group.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aortic Coarctation; Cryotherapy; Diagnosis, Differential; Esthetics; Eye Abnormalities; Glucocorticoids; Hemangioma; Humans; Immunosuppressive Agents; Infant; Laser Therapy; Neurocutaneous Syndromes; Phototherapy; Propranolol; Risk Factors; Sirolimus; Vascular Neoplasms; Watchful Waiting | 2015 |
Medical management of vascular anomalies.
Topics: Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Bevacizumab; Clinical Decision-Making; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Interferons; Propranolol; Sildenafil Citrate; Sirolimus; Thalidomide; Vascular Malformations | 2016 |
24 other study(ies) available for propranolol and sirolimus
| Article | Year |
|---|---|
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin.
Topics: Animals; Caco-2 Cells; Everolimus; Humans; Immunosuppressive Agents; Intestinal Absorption; Mannitol; Propranolol; Rats; Rats, Wistar; Sirolimus; Verapamil | 1998 |
beta-agonists regulate Na,K-ATPase via novel MAPK/ERK and rapamycin-sensitive pathways.
Topics: Adrenergic beta-Agonists; Animals; Cell Membrane; Cells, Cultured; Colforsin; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Epithelial Cells; Isoproterenol; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Propranolol; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Sirolimus; Sodium-Potassium-Exchanging ATPase | 2000 |
Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cyclosporine; Drug Interactions; Heart Rate; Hemodynamics; Immunosuppressive Agents; Indans; Infusions, Intravenous; Losartan; Male; Phentolamine; Propranolol; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renal Circulation; Sirolimus; Tacrolimus | 2004 |
Treatment of a tongue lymphangioma with sirolimus after failure of surgical resection and propranolol.
Topics: Adrenergic beta-Antagonists; Antibiotics, Antineoplastic; Child; Combined Modality Therapy; Humans; Lymphangioma; Male; Postoperative Complications; Propranolol; Sirolimus; Tongue Neoplasms; Treatment Outcome | 2014 |
[Medication-based therapy of infantile hemangioma and lymphatic malformations].
Topics: Antibiotics, Antineoplastic; Female; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Infant, Newborn; Lymphatic Abnormalities; Lymphatic Vessel Tumors; Male; Propranolol; Sirolimus; Vasodilator Agents | 2014 |
Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells.
Topics: Cell Differentiation; Cell Proliferation; Child; Child, Preschool; Endothelial Cells; Female; Glucose Transporter Type 1; Hemangioma; Humans; Infant; Male; Neoplastic Stem Cells; Propranolol; Sirolimus; Stem Cells | 2015 |
Successful treatment of Kaposiform hemangioendothelioma with everolimus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Drug Resistance, Neoplasm; Everolimus; Hemangioendothelioma; Humans; Immunosuppressive Agents; Kasabach-Merritt Syndrome; Male; Prednisolone; Propranolol; Sarcoma, Kaposi; Sirolimus; Vincristine | 2015 |
Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Lipogenesis; Male; Molecular Targeted Therapy; Nuclear Proteins; Phosphatidate Phosphatase; Phosphorylation; Propranolol; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; rhoA GTP-Binding Protein; Ribosomal Protein S6; RNA Interference; Signal Transduction; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Transfection | 2015 |
Characterization of Endothelial Microparticles Induced by Different Therapeutic Drugs for Infantile Hemangioma.
Topics: Cells, Cultured; Dexamethasone; Endothelium, Vascular; Flow Cytometry; Hemangioma; Human Umbilical Vein Endothelial Cells; Humans; MicroRNAs; Microscopy, Electron, Transmission; Neovascularization, Pathologic; Propranolol; Sirolimus; Vascular Endothelial Growth Factor A | 2015 |
A novel case of lymphangiomatosis in HIV.
Topics: Antirheumatic Agents; Bevacizumab; Cell Proliferation; HIV Infections; Humans; Lung; Lymphangioma; Lymphatic Vessels; Male; Middle Aged; Pleural Effusion; Propranolol; Sirolimus; Tomography, X-Ray Computed | 2017 |
Diffuse Hepatic Hemangiomas Successfully Treated Using Sirolimus and High-Dose Propranolol.
Topics: Adrenergic beta-Antagonists; Hemangioma; Humans; Immunosuppressive Agents; Infant, Newborn; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Propranolol; Sirolimus; Treatment Outcome | 2017 |
[Benign aggressive vascular anomalies in children].
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Arteriovenous Malformations; Child; Child, Preschool; Hemangioma; Humans; Infant; Kasabach-Merritt Syndrome; Neoplasms, Vascular Tissue; Propranolol; Rare Diseases; Sirolimus; Vascular Malformations; Vasodilator Agents | 2018 |
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Drug Therapy, Combination; Hemangioendothelioma; Humans; Immunosuppressive Agents; Infant; Kasabach-Merritt Syndrome; Male; Pneumocystis carinii; Pneumonia, Pneumocystis; Prednisolone; Propranolol; Respiratory Insufficiency; Sarcoma, Kaposi; Sirolimus; Vincristine | 2018 |
β-Arrestin2 Inhibits Expression of Inflammatory Cytokines in BEAS-2B Lung Epithelial Cells Treated with Cigarette Smoke Condensate via Inhibition of Autophagy.
Topics: AMP-Activated Protein Kinases; Autophagy; Autophagy-Related Proteins; beta-Arrestin 2; Cell Line; Chemokine CCL2; Epithelial Cells; Humans; Interleukin-6; Lung; Microscopy, Confocal; Nicotiana; Propranolol; RNA Interference; RNA, Small Interfering; Signal Transduction; Sirolimus; Smoke; TOR Serine-Threonine Kinases | 2018 |
Successful Medical Management of Life-threatening Hepatic Hemangioma in Neonates.
Topics: Drug Therapy, Combination; Embolization, Therapeutic; Female; Glucocorticoids; Hemangioma; Hepatic Artery; Humans; Infant, Newborn; Liver Neoplasms; Male; Methylprednisolone; Propranolol; Sirolimus; Vasodilator Agents | 2019 |
Sirolimus and propranolol inhibit endothelial proliferation while detergent sclerosants induce endothelial activation, microparticle release and apoptosis in vitro.
Topics: Animals; Apoptosis; Cell Proliferation; Detergents; Human Umbilical Vein Endothelial Cells; Humans; Mice; Propranolol; Sclerosing Solutions; Sirolimus; Sodium Tetradecyl Sulfate | 2020 |
Propranolol-resistant infantile hemangioma successfully treated with sirolimus.
Topics: Adrenergic beta-Antagonists; Child; Hemangioma; Hemangioma, Capillary; Humans; Infant; Prednisolone; Propranolol; Sirolimus; Treatment Outcome | 2020 |
Effective Initial Treatment of Diffuse Pulmonary Lymphangiomatosis with Sirolimus and Propranolol: A Case Report.
Topics: Child; Female; Humans; Lung Diseases; Lymphangiectasis; Male; Propranolol; Sirolimus; Treatment Outcome | 2021 |
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro.
Topics: Adrenergic beta-Antagonists; Amines; Atenolol; Autophagy; Cell Proliferation; Child; Endothelial Cells; Hemangioma; Humans; Macrolides; Metoprolol; Propranolol; Sirolimus | 2022 |
Severe consumptive hypothyroidism in hepatic hemangioendothelioma.
Topics: Hemangioendothelioma; Humans; Hypothyroidism; Infant; Liver Neoplasms; Male; Propranolol; Sirolimus; Thyroid Hormones; Thyroxine; Triiodothyronine | 2022 |